The Rx-to-OTC switch of Claritin, Allegra, and Zyrtec: an unprecedented FDA response to petitioners and the protection of public health. [electronic resource]
Producer: 20020830Description: 999-1050 p. digitalISSN:- 0003-1453
- Anti-Allergic Agents
- Cetirizine
- Drug Approval
- Drug Costs
- Drug Labeling
- Drug Prescriptions -- economics
- Gatekeeping -- legislation & jurisprudence
- Humans
- Legislation, Drug
- Loratadine
- Nonprescription Drugs -- economics
- Public Health Practice
- Terfenadine -- analogs & derivatives
- United States
- United States Food and Drug Administration -- legislation & jurisprudence
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.